28399871|t|IGF2BP3 functions as a potential oncogene and is a crucial target of miR-34a in gastric carcinogenesis
28399871|a|Gastric cancer (GC) is one of the frequent causes of cancer -related death in eastern Asian population. IGF2BP2 lists in the top rank up-regulated genes in GC, but its functional role is unclear. The expression of IGF2BP3 in GC cell lines and primary samples was examined by qRT-PCR and Western blot. The biological role of IGF2BP3 was revealed by a series of functional in vitro studies. Its regulation by microRNAs (miRNAs) was predicted by TargetScan and confirmed by luciferase assays and rescue experiments. IGF2BP3 ranked the No.1 of the up-regulated genes by expression microarray analysis in GC cell line s. The expression level of IGF2BP3 was observed in GC tissues comparing with non-tumorous gastric epitheliums. The up-regulated IGF2BP3 expression was associated with poor disease specific survival. IGF2BP3 knockdown significantly inhibited cell proliferation and invasion. Apart from copy number gain, IGF2BP3 has been confirmed to be negatively regulated by tumor-suppressive miRNA, namely miR-34a. The expression of miR-34a showed negative correlation with IGF2BP3 mRNA expression in primary GC samples and more importantly, re-overexpression of IGF2BP3 rescued the inhibitory effect of miR-34a. We compressively revealed the oncogenic role of IGF2BP3 in gastric tumorigenesis and confirmed its activation is partly due to the silence of miR-34a. Our findings identified useful prognostic biomarker and provided clinical translational potential.
28399871	0	7	IGF2BP3	T028	C1825578
28399871	8	17	functions	T169	C0542341
28399871	23	32	potential	T080	C3245505
28399871	33	41	oncogene	T028	C0029016
28399871	59	65	target	T169	C1521840
28399871	69	76	miR-34a	T114	C2351044
28399871	80	102	gastric carcinogenesis	T191	C0024623
28399871	103	117	Gastric cancer	T191	C0024623
28399871	119	121	GC	T191	C0024623
28399871	137	145	frequent	T079	C0332183
28399871	156	162	cancer	T191	C0006826
28399871	172	177	death	T040	C0011065
28399871	181	205	eastern Asian population	T081	C0032659
28399871	207	214	IGF2BP2	T028	C1825577
28399871	237	255	up-regulated genes	T044	C0041904
28399871	259	261	GC	T191	C0024623
28399871	271	286	functional role	T169	C0542341
28399871	290	297	unclear	T033	C3845108
28399871	303	313	expression	T045	C0017262
28399871	317	324	IGF2BP3	T028	C1825578
28399871	328	330	GC	T191	C0024623
28399871	331	341	cell lines	T025	C0007601
28399871	346	353	primary	T080	C0205225
28399871	354	361	samples	T077	C2347026
28399871	366	374	examined	T033	C0332128
28399871	378	385	qRT-PCR	T063	C1514628
28399871	390	402	Western blot	T059	C0949466
28399871	408	423	biological role	T038	C3714634
28399871	427	434	IGF2BP3	T028	C1825578
28399871	439	447	revealed	T080	C0443289
28399871	463	473	functional	T169	C0205245
28399871	474	490	in vitro studies	T062	C0681828
28399871	496	506	regulation	T045	C0017263
28399871	510	519	microRNAs	T114,T123	C1101610
28399871	521	527	miRNAs	T114,T123	C1101610
28399871	533	542	predicted	T078	C0681842
28399871	546	556	TargetScan	T060	C0441633
28399871	574	591	luciferase assays	T116,T126,T130	C0024075
28399871	596	602	rescue	T074	C0182965
28399871	603	614	experiments	T062	C0681814
28399871	616	623	IGF2BP3	T028	C1825578
28399871	647	665	up-regulated genes	T044	C0041904
28399871	669	679	expression	T045	C0017262
28399871	680	699	microarray analysis	T059	C1449575
28399871	703	705	GC	T191	C0024623
28399871	706	715	cell line	T025	C0007601
28399871	723	733	expression	T045	C0017262
28399871	743	750	IGF2BP3	T028	C1825578
28399871	755	763	observed	T169	C1441672
28399871	767	769	GC	T191	C0024623
28399871	770	777	tissues	T024	C0040300
28399871	793	825	non-tumorous gastric epitheliums	T023	C0227208
28399871	831	843	up-regulated	T044	C0041904
28399871	844	851	IGF2BP3	T028	C1825578
28399871	852	862	expression	T045	C0017262
28399871	867	882	associated with	T080	C0332281
28399871	883	913	poor disease specific survival	T081	C2986538
28399871	915	922	IGF2BP3	T028	C1825578
28399871	923	932	knockdown	T063	C2350567
28399871	933	946	significantly	T078	C0750502
28399871	947	956	inhibited	T080	C0311403
28399871	957	975	cell proliferation	T043	C0596290
28399871	980	988	invasion	T033	C1269955
28399871	1001	1017	copy number gain	T081	C1517378
28399871	1019	1026	IGF2BP3	T028	C1825578
28399871	1052	1062	negatively	T033	C0205160
28399871	1063	1072	regulated	T045	C0017263
28399871	1076	1093	tumor-suppressive	T044	C1519692
28399871	1094	1099	miRNA	T114,T123	C1101610
28399871	1108	1115	miR-34a	T114	C2351044
28399871	1121	1131	expression	T045	C0017262
28399871	1135	1142	miR-34a	T028	C1537745
28399871	1150	1158	negative	T077	C2825415
28399871	1159	1170	correlation	T080	C1707520
28399871	1176	1183	IGF2BP3	T028	C1825578
28399871	1184	1188	mRNA	T114,T123	C0035696
28399871	1189	1199	expression	T045	C0017262
28399871	1203	1210	primary	T080	C0205225
28399871	1211	1213	GC	T191	C0024623
28399871	1214	1221	samples	T077	C2347026
28399871	1244	1261	re-overexpression	T045	C0017262
28399871	1265	1272	IGF2BP3	T028	C1825578
28399871	1285	1302	inhibitory effect	T043	C1708997
28399871	1306	1313	miR-34a	T114	C2351044
28399871	1332	1340	revealed	T080	C0443289
28399871	1345	1354	oncogenic	T028	C0029016
28399871	1355	1359	role	T045	C0314627
28399871	1363	1370	IGF2BP3	T028	C1825578
28399871	1374	1395	gastric tumorigenesis	T191	C0038356
28399871	1414	1424	activation	T052	C1879547
28399871	1446	1453	silence	T045	C0598496
28399871	1457	1464	miR-34a	T114	C2351044
28399871	1470	1478	findings	T033	C0243095
28399871	1479	1489	identified	T080	C0205396
28399871	1497	1517	prognostic biomarker	T080	C1514475
28399871	1531	1539	clinical	T080	C0205210
28399871	1540	1553	translational	T045	C1519614
28399871	1554	1563	potential	T080	C3245505